Scorpius Holdings Inc (SCPX)
0.0315
0.00 (0.00%)
USD |
NYAM |
Jun 24, 16:00
Scorpius Holdings Profit Margin (Quarterly): -125.7% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -125.7% |
December 31, 2023 | -111.6% |
September 30, 2023 | -1.82K% |
June 30, 2023 | -2.11K% |
March 31, 2023 | -1.67K% |
December 31, 2022 | -19.05K% |
September 30, 2022 | -22.52K% |
June 30, 2022 | -13.40K% |
March 31, 2022 | -3.82K% |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | -1.42K% |
March 31, 2021 | -1.40K% |
December 31, 2020 | -1.07K% |
September 30, 2020 | -1.04K% |
June 30, 2020 | -751.0% |
March 31, 2020 | -697.7% |
December 31, 2019 | -166.9% |
September 30, 2019 | -96.20K% |
June 30, 2019 | -1.39K% |
March 31, 2019 | -815.3% |
December 31, 2018 | -239.9% |
September 30, 2018 | -198.8% |
June 30, 2018 | -333.7% |
Date | Value |
---|---|
March 31, 2018 | -441.4% |
December 31, 2017 | -510.4% |
September 30, 2017 | -488.7% |
June 30, 2017 | |
March 31, 2017 | -13.16K% |
December 31, 2016 | -2.86K% |
September 30, 2016 | -734.2% |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | -18.26K% |
June 30, 2012 | -21.22K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-96.20K%
Minimum
Sep 2019
-111.6%
Maximum
Dec 2023
-9.38K%
Average
-1.41K%
Median
Profit Margin (Quarterly) Benchmarks
Biolase Inc | -64.01% |
GT Biopharma Inc | -- |
Akoya Biosciences Inc | -128.0% |
NovaBay Pharmaceuticals Inc | -122.2% |
Palatin Technologies Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -94.78% |
Return on Assets | -53.69% |
Return on Invested Capital | -93.77% |
Gross Profit Margin (Quarterly) | 73.30% |
Operating Margin (Quarterly) | -179.9% |
Return on Net Operating Assets | -73.13% |